Human Written & Fact Checked · Updated
161 Skincare Industry Statistics for 2026
Skincare took 38% of the world beauty market in 2025 on L'Oréal's own estimate at manufacturer prices, Europeans spent €32.3 billion on skin care at retail on Cosmetics Europe's figures, and South Korea exported $8.53 billion of basic skincare products.
This page gathers the latest skincare industry statistics: the size of the category on the two main estimates, skincare sales at L'Oréal, Beiersdorf, Galderma, Estée Lauder, P&G, Shiseido, Kao and Amorepacific, US prices and Ulta Beauty's sales mix, EU and Korean trade and production, the rules on sunscreen filters and skincare ingredients in the US, the EU and Australia, product safety alerts, and sunburn and melanoma. Every number links to the body that published it, with the date.
Skincare figures measure different things. A company estimate at manufacturer prices, an industry body's retail figure, customs records for a tariff heading that also covers make-up and sunscreen, a Korean regulator's skincare category and company accounts each count something else. Each figure here says what it measures and who produced it, and figures on different bases are not merged or compared.
Headline figures
- Skincare made up 38% of the world beauty market in 2025 on L'Oréal's own estimate, which values the market at net manufacturer prices and excludes soap, toothpaste, razors and blades. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- Skin care is the biggest cosmetics and personal care category in Europe, with retail sales of €32.3 billion in 2025 on Cosmetics Europe's estimate. (Cosmetics Europe (Our Industry), Nov 2026)
- Sales at L'Oréal's Dermatological Beauty Division (La Roche-Posay, CeraVe, Vichy, SkinCeuticals) rose 11.6% like-for-like in the first nine months of 2026, to €6,087.4 million. (L'Oréal (sales at 30 September 2026), Oct 2026)
- Beiersdorf's Derma business (Eucerin and Aquaphor) had sales of €1,492 million in 2025, up 11.7% organically, its fifth consecutive year of double-digit growth. (Beiersdorf (2025 results), Mar 2026)
- Galderma's Dermatological Skincare category (Cetaphil, Alastin) had net sales of $1,449 million in 2025, up 9.3% at constant currency. (Galderma (2025 results), Mar 2026)
- The Estée Lauder Companies' skin care net sales were $7,338 million in fiscal 2026, the year to 30 June 2026, worldwide. (Estée Lauder Companies (FY2026 results), Aug 2026)
- Skincare and wellness made up 24% of Ulta Beauty's net sales in fiscal 2025, the year to 31 January 2026, on Ulta's approximate category split. (Ulta Beauty (Form 10-K fiscal 2025), Mar 2026)
- US consumer prices for cosmetics, perfume, bath and nail preparations rose 1.4% in the 12 months to September 2026, against 3.7% for all items. (BLS (CPI-U series CUUR0000SEGB02, 12-month change), Nov 2026)
- The EU exported €12.10 billion of other beauty or make-up and skin-care preparations (HS 3304.99) to countries outside the EU in 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU imports of other beauty or make-up and skin-care preparations (HS 3304.99) from South Korea reached €944 million in 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- South Korea exported $8.53 billion of basic skincare products in 2025, 74.7% of its cosmetics exports, on Ministry of Food and Drug Safety statistics. (MFDS (2025 cosmetics statistics), May 2026)
- Of the 16 sunscreen active ingredients allowed in the US, FDA's proposed order gives generally recognized as safe and effective (GRASE) status to only 2: zinc oxide and titanium dioxide. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- 35.1% of US adults, an estimated 88.1 million, had at least one sunburn in the previous 12 months in 2024. (CDC (MMWR, sunburn among US adults 2024), May 2026)
- An estimated 112,000 new cases of melanoma of the skin will be diagnosed in the US in 2026, 5.3% of all new cancer cases. (NCI SEER (Cancer Stat Facts: Melanoma of the Skin), Nov 2026)
How big is the skincare market?
Cosmetics Europe names skin care the biggest product category in Europe, and skincare comes first in L'Oréal's own split of the world beauty market. The two producers measure different things, L'Oréal at net manufacturer prices worldwide and Cosmetics Europe at retail value in Europe, so their figures are given separately and never added or compared.
- L'Oréal estimates the worldwide beauty market was worth about €300 billion in 2025, on net manufacturer prices at constant exchange rates, excluding soap, toothpaste, razors and blades. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- In the same L'Oréal estimate, haircare took 21% of the 2025 world beauty market, make-up 17%, perfumes 14% and hygiene products 10%. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- L'Oréal says the global dermocosmetics market slowed in 2025 but still grew faster than the beauty category as a whole, and that its Dermatological Beauty Division outperformed that market in sell-out. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- Beiersdorf said its 2025 NIVEA performance reflected "the marked slowdown in the global skin care market" as well as a repositioning of its business in China. (Beiersdorf (2025 results), Mar 2026)
- European retail sales of cosmetics and personal care products were valued at €110 billion in 2025, on Cosmetics Europe's estimate. (Cosmetics Europe (Our Industry), Nov 2026)
- After skin care, Cosmetics Europe puts 2025 European retail sales of toiletries at €26.4 billion, hair care at €20.3 billion, fragrances and perfumes at €17.1 billion and decorative cosmetics at €13.6 billion. (Cosmetics Europe (Our Industry), Nov 2026)
- Skin care held 29.4% of the European cosmetics and personal care market by retail value in 2025, the largest share of any category, according to Cosmetics Europe. (Cosmetics Europe (socio-economic infographic 2026), Oct 2026)
- Cosmetics Europe puts the 2025 market shares of toiletries at 24.1%, hair care 18.5%, fragrances 15.6% and decorative cosmetics 12.4%. (Cosmetics Europe (socio-economic infographic 2026), Oct 2026)
- Germany (€18.0 billion) and the UK (€14.7 billion) are the biggest European cosmetics and personal care markets by retail sales, followed by France (€14.5 billion), Italy (€12.8 billion), Spain (€11.8 billion) and Poland (€6.4 billion), on Cosmetics Europe figures for 2025. (Cosmetics Europe (Our Industry), Nov 2026)
- 91% of European consumers have a personal care routine and 73% say it supports their wellbeing and healthy ageing, in Cosmetics Europe's European Consumer Perception Study 2026. (Cosmetics Europe (socio-economic infographic 2026), Oct 2026)
L'Oréal's figures are the company's own estimate of the world beauty market at net manufacturer prices, excluding soap, toothpaste, razors and blades, at constant exchange rates. Cosmetics Europe's figures are retail sales values for Europe as Cosmetics Europe defines it, which goes beyond the EU. The two bases are different and are not compared or combined. Routine figures cover all personal care, including skin care, and the infographic does not state the survey's sample.
How much skincare does L'Oréal sell?
L'Oréal's skincare sales were almost flat in 2025 on a like-for-like basis, well behind its haircare and perfume growth. Its Dermatological Beauty Division, home of La Roche-Posay and CeraVe, grew faster and sped up into 2026.
View data table
| Period | Value |
|---|---|
| 2023 | €16,447.1m |
| 2024 | €16,803.7m |
| 2025 | €16,383.5m |
- L'Oréal Group skincare sales were €16,383.5 million in 2025, up 0.4% like-for-like, across all four of its divisions worldwide. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- L'Oréal's total beauty sales grew 4.0% like-for-like in 2025, its haircare sales 12.9% and its perfume sales 10.4%. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- L'Oréal's Dermatological Beauty Division (La Roche-Posay, CeraVe, Vichy, SkinCeuticals and others) had sales of €7,204.1 million in 2025, 16.4% of group sales, up 5.5% like-for-like. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- Dermatological Beauty made an operating profit of €1,882.1 million in 2025, an operating margin of 26.1%. (L'Oréal (2025 Universal Registration Document), Mar 2026)
- L'Oréal's other three divisions had 2025 operating margins of 22.9% (Professional Products), 22.4% (Luxe) and 21.4% (Consumer Products). (L'Oréal (2025 Universal Registration Document), Mar 2026)
- L'Oréal says Dermatological Beauty's momentum improved quarter after quarter in 2025 and "significantly accelerated into double digits in the fourth quarter". (L'Oréal (2025 Universal Registration Document), Mar 2026)
- In the third quarter of 2026 alone, Dermatological Beauty sales were €1,871.6 million, up 12.2% like-for-like. (L'Oréal (sales at 30 September 2026), Oct 2026)
- L'Oréal says all three of the dermatological brands it calls "billionaire" brands, La Roche-Posay, CeraVe and SkinCeuticals, grew in double digits in the first nine months of 2026. (L'Oréal (sales at 30 September 2026), Oct 2026)
- L'Oréal's chief executive said in October 2026 that the group is "now also outperforming the market in the all-important skincare category". (L'Oréal (sales at 30 September 2026), Oct 2026)
L'Oréal figures are the company's own, for calendar years, worldwide. Like-for-like growth is at constant group structure and exchange rates. Skincare is a product category across all four divisions; Dermatological Beauty is a division that also sells some haircare, so the two are not the same thing and are not added. "All-important" and "outperforming" are L'Oréal's own words.
How are Beiersdorf and Galderma's skincare businesses doing?
At Beiersdorf, the Derma brands Eucerin and Aquaphor are growing while NIVEA shrinks in 2026, and the company now expects its consumer sales to fall slightly this year. Galderma's skincare sales, led by Cetaphil, are growing at double-digit rates in 2026.
- Beiersdorf's skin care business grew 3.7% organically in 2025; Beiersdorf calls itself "the fastest growing skin care company globally", a claim the company makes about itself. (Beiersdorf (2025 results), Mar 2026)
- NIVEA (including Labello) had sales of €5,529 million in 2025, down 1.3% in nominal terms and up 0.9% organically. (Beiersdorf (2025 results), Mar 2026)
- Beiersdorf's luxury skin care brand La Prairie had sales of €478 million in 2025, down 4.5% organically, but returned to 3.8% organic growth in the fourth quarter. (Beiersdorf (2025 results), Mar 2026)
- Beiersdorf's Consumer Business, which holds its skin care brands, had sales of €8.2 billion in 2025, up 2.5% organically; group sales of €9.9 billion include €1.7 billion from tesa adhesives. (Beiersdorf (2025 results), Mar 2026)
- In the first nine months of 2026, Beiersdorf's Derma sales rose 8.7% organically to €1,238 million, while NIVEA (including Labello) fell 6.2% organically to €3,966 million. (Beiersdorf (Q3 2026 results), Oct 2026)
- In the third quarter of 2026, Derma grew 10.6% organically and La Prairie 8.5%, while NIVEA sales fell 4.9% organically. (Beiersdorf (Q3 2026 results), Oct 2026)
- On 3 August 2026 Beiersdorf cut its 2026 outlook for the Consumer Business to a low-single-digit organic sales decline, from "flat to slightly growing", and confirmed it on 27 October 2026. (Beiersdorf (H1 2026 results), Aug 2026)
- Beiersdorf launched an 18-month NIVEA turnaround plan in August 2026 and said it would raise NIVEA media spend by €100 million in the second half of 2026 against the same half of 2025. (Beiersdorf (H1 2026 results), Aug 2026)
- Galderma's group net sales were $5,207 million in 2025, including injectables and prescription dermatology; it says Cetaphil and Alastin grew faster than their segments worldwide. (Galderma (2025 results), Mar 2026)
- Galderma's Dermatological Skincare net sales were $1,244 million in the first nine months of 2026, up 16.2% at constant currency. (Galderma (Q3 2026 results), Oct 2026)
- Galderma has agreed to buy ZO Skin Health, a physician-dispensed skincare brand founded in 2007 by Dr. Zein Obagi, with the deal expected to close in the fourth quarter of 2026 or early 2027. (Galderma (Q3 2026 results), Oct 2026)
Each figure is the company's own, worldwide, for calendar years or parts of 2026. Organic growth (Beiersdorf) and constant-currency growth (Galderma) are each company's own measure, and the two companies are not compared. NIVEA includes deodorants and body care as well as face care. Beiersdorf's 2026 outlook is a company forecast. The ZO Skin Health deal had not closed at the date of the release.
How much skincare do Estée Lauder and P&G sell?
Skin care is growing again at the Estée Lauder Companies, led by La Mer and The Ordinary, and its skin care operating income rose sharply in fiscal 2026. At Procter & Gamble, skin care grew at a mid-single-digit rate, led by SK-II.
View data table
| Period | Value |
|---|---|
| FY2025 | $6,962m |
| FY2026 | $7,338m |
- Estée Lauder's skin care net sales rose 5% reported and 4% organically in fiscal 2026, from $6,962 million, "primarily driven by growth from La Mer, The Ordinary and Estée Lauder". (Estée Lauder Companies (FY2026 results), Aug 2026)
- Estée Lauder's skin care net sales were $1,853 million in the fourth quarter of fiscal 2026 (April to June 2026), up 9% reported and 7% organically from $1,705 million. (Estée Lauder Companies (FY2026 results), Aug 2026)
- Estée Lauder's reported skin care operating income was $1,416 million in fiscal 2026, against $574 million in fiscal 2025; on the company's adjusted basis, skin care operating income rose 52%. (Estée Lauder Companies (FY2026 results), Aug 2026)
- In the first quarter of fiscal 2027 (July to September 2026), Estée Lauder's skin care net sales were $1,651 million, up from $1,575 million, driven mainly by La Mer and The Ordinary. (Estée Lauder Companies (Q1 FY2027 results), Nov 2026)
- Procter & Gamble's Beauty segment net sales rose 7% to $16.0 billion in fiscal 2026 (year to 30 June 2026), on a 4% rise in unit volume; the segment also includes hair care and personal care. (P&G (Form 10-K fiscal 2026), Aug 2026)
- P&G says its Skin Care net sales, from brands including Olay and SK-II, "increased mid-single digits" in fiscal 2026, helped mainly by growth of the super-premium SK-II brand. (P&G (Form 10-K fiscal 2026), Aug 2026)
Figures are each company's own, worldwide, for financial years ending 30 June. Organic growth excludes the impact of foreign currency translation. Estée Lauder's reported and adjusted operating income are different measures. P&G does not give a skin care dollar figure in the text cited, and the two companies are not compared.
How are Japanese and Korean skincare companies doing?
Japan's skin care market was flat in value at the end of 2025 while sunscreens grew, on INTAGE panel data. Shiseido forecasts higher sales in 2026, and Korea's Amorepacific grew its overseas sales by double digits in 2025, most of all in EMEA.
View data table
| Period | Value |
|---|---|
| Skin care products | 100 |
| Sunscreens | 107 |
| Make-up products | 97 |
- Shiseido had net sales of JPY 970.0 billion in 2025 (January to December) and core operating profit of JPY 44.5 billion, a 4.6% margin, across all its categories. (Shiseido (FY2025 results presentation), Feb 2026)
- Shiseido forecasts net sales of JPY 990.0 billion for 2026. (Shiseido (FY2025 results presentation), Feb 2026)
- Net sales of Shiseido's ANESSA sunscreen brand fell 9% in 2025, though they rose 6% in the second half, while its ELIXIR skincare brand grew 9%. (Shiseido (FY2025 results presentation), Feb 2026)
- Shiseido says ELIXIR renewed its number one ranking in skin care sales in Japan for 19 consecutive years, a company claim that does not name its data source. (Shiseido (FY2025 earnings call), Feb 2026)
- Kao's Health Beauty Care business, which includes Bioré, Curél and Jergens skin care, had 2025 sales of JPY 432.9 billion, up 2.2% like-for-like; its Cosmetics business had sales of JPY 261.6 billion, up 6.9%. (Kao (FY2025 results), Feb 2026)
- Japan's skin care products market was flat in value in the fourth quarter of 2025 against a year earlier, while sunscreens in the cosmetics channel grew 7% and make-up fell 3%, on INTAGE retail panel data published by Kao. (INTAGE via Kao (FY2025 results), Feb 2026)
- Amorepacific Group, whose brands include Sulwhasoo, Laneige, Innisfree, COSRX and Aestura, reported consolidated revenue of KRW 4.6232 trillion and operating profit of KRW 368 billion in 2025. (Amorepacific Group (2025 results), Feb 2026)
- Amorepacific's overseas revenue rose 15% in 2025, with revenue up 20% in the Americas and 42% in EMEA. (Amorepacific Group (2025 results), Feb 2026)
- Amorepacific calls AESTURA "Korea's leading derma brand" and says Sulwhasoo "solidified its leadership in the luxury skincare market" in 2025; neither claim comes with figures. (Amorepacific Group (2025 results), Feb 2026)
Shiseido, Kao and Amorepacific figures are group or business totals covering more than skincare, for calendar 2025, in their own currencies; none publishes a skincare-only total in the documents cited. Shiseido's brand growth rates are on its own like-for-like basis. INTAGE indices cover Japan only. The 2026 Shiseido figure is a forecast.
How fast are US beauty prices rising, and how much skincare does Ulta sell?
US prices for cosmetics, perfume, bath and nail products are rising more slowly than prices in general, and there is no skincare-only US price index. At Ulta Beauty, skincare and wellness has taken a bigger share of sales each year since fiscal 2023, while cosmetics has lost share.
View data table
| Period | Value |
|---|---|
| Jan | 1.4% |
| Feb | 1.5% |
| Mar | 2.0% |
| Apr | 2.8% |
| May | 3.0% |
| Jun | 2.2% |
| Jul | 3.0% |
| Aug | 2.8% |
| Sep | 1.4% |
- The US CPI index for cosmetics, perfume, bath, nail preparations and implements stood at 195.050 in September 2026 (1982-84=100), up from 192.368 in September 2025. (BLS (CPI-U series CUUR0000SEGB02), Nov 2026)
- The 12-month rate of price change for the same item was 3.0% in May and July 2026 and 2.8% in April and August. (BLS (CPI-U series CUUR0000SEGB02, 12-month change), Nov 2026)
- US prices for all personal care products rose 2.1% in the 12 months to September 2026. (BLS (CPI-U series CUUR0000SEGB, 12-month change), Nov 2026)
- Skincare and wellness made up 23% of Ulta Beauty's net sales in fiscal 2024 and 22% in fiscal 2023. (Ulta Beauty (Form 10-K fiscal 2025), Mar 2026)
- Cosmetics made up 38% of Ulta's net sales in fiscal 2025, down from 39% in fiscal 2024 and 41% in fiscal 2023. (Ulta Beauty (Form 10-K fiscal 2025), Mar 2026)
- Haircare made up 19% of Ulta's fiscal 2025 net sales and fragrance 13%. (Ulta Beauty (Form 10-K fiscal 2025), Mar 2026)
- Ulta Beauty's net sales rose 9.7% to $12.4 billion in fiscal 2025, from $11.3 billion in fiscal 2024. (Ulta Beauty (Form 10-K fiscal 2025), Mar 2026)
BLS figures are the CPI-U, US city average, not seasonally adjusted. The cosmetics item covers perfume, bath and nail preparations as well as skin care, and BLS publishes no skincare-only index. Index values show price change since 1982-84, not prices. October 2025 has no CPI data because of the 2025 lapse in US federal funding. Ulta's category shares are its own approximate figures for its US stores and website, with skincare combined with wellness; they are not a measure of the US market and are not compared with the price index.
How much do EU exports of beauty and skin-care preparations earn?
EU exports of these preparations to non-EU countries rose slightly in 2025, with China, the US and the UK among the main buyers, while sales to the US fell. The heading, HS 3304.99, covers "other beauty or make-up preparations and preparations for the care of the skin", including sunscreen, so it is wider than skincare alone.
- The EU exported €11.93 billion of other beauty or make-up and skin-care preparations (HS 3304.99) to non-EU countries in both 2023 and 2024. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- Extra-EU exports of other beauty or make-up and skin-care preparations (HS 3304.99) weighed 552,201 tonnes in 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- Non-EU buyers of EU other beauty or make-up and skin-care preparations (HS 3304.99) in 2025 included China (€1.75 billion), the US (€1.31 billion), the UK (€1.27 billion), Singapore (€790 million), Switzerland (€626 million), Hong Kong (€554 million) and the UAE (€471 million). (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU exports of other beauty or make-up and skin-care preparations (HS 3304.99) to the US fell in 2025 from €1.48 billion in 2024; they had been €0.98 billion in 2021. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU exports of other beauty or make-up and skin-care preparations (HS 3304.99) to China were €1.63 billion in 2024 and €1.91 billion in 2023. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- France exported €5.64 billion of other beauty or make-up and skin-care preparations (HS 3304.99) to non-EU countries in 2025, Germany €1.37 billion, Spain €955 million, Italy €885 million and Poland €731 million; member-state figures can include re-exports. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- Extra-EU exports of all beauty, make-up and skin-care preparations (HS 3304, which adds lip, eye and nail make-up and powders) were €15.31 billion in 2025, and of all essential oils, perfumery and cosmetic products (HS chapter 33) €46.15 billion. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- Monthly extra-EU exports of other beauty or make-up and skin-care preparations (HS 3304.99) were €1.16 billion in July 2026, against €1.08 billion in July 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU exports of other beauty or make-up and skin-care preparations (HS 3304.99) to the US were €138.1 million in July 2026, against €115.1 million in July 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU manufacturers sold an estimated €12.17 billion of beauty, make-up and skin care preparations including suntan products (Prodcom 20421500) in 2024, up from €12.13 billion in 2023, both Eurostat estimates. (Eurostat (Prodcom sold production, DS-059358), Oct 2026)
- Sold production of beauty, make-up and skin care preparations including suntan products (Prodcom 20421500) was €5.04 billion in France in 2024, €2.12 billion in Germany, €1.37 billion in Spain, €1.34 billion in Poland and €1.19 billion in Italy; some member states' figures are confidential. (Eurostat (Prodcom sold production, DS-059358), Oct 2026)
Trade values are EU27 trade with non-EU countries in current euros, from Eurostat Comext. HS 3304.99 covers other beauty or make-up preparations and preparations for the care of the skin, including sunscreen and tanning preparations and some make-up such as foundations, and excludes medicaments. Production values are Eurostat Prodcom sold production at producer prices for 2024, a related but different code and measure; production and trade are not combined or compared. Partners are listed by value; Eurostat does not publish a ranking. Monthly 2026 figures are provisional. HS 3304.99 is not compared with Korea's skincare category.
Where does the EU import beauty and skin-care preparations from?
The EU buys far less of these preparations from outside the bloc than it sells, and South Korea is now one of its main suppliers, with monthly imports in 2026 well above 2025 levels. As with exports, the heading HS 3304.99 covers make-up and sunscreen as well as skin care.
View data table
| Period | Value |
|---|---|
| 2021 | €215m |
| 2023 | €379m |
| 2024 | €593m |
| 2025 | €944m |
- The EU imported €3.80 billion of other beauty or make-up and skin-care preparations (HS 3304.99) from outside the EU in 2025, up from €3.47 billion in 2024. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- Extra-EU imports of other beauty or make-up and skin-care preparations (HS 3304.99) weighed 154,141 tonnes in 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU imports of other beauty or make-up and skin-care preparations (HS 3304.99) from South Korea were €593 million in 2024, €379 million in 2023 and €215 million in 2021. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- Other non-EU suppliers of other beauty or make-up and skin-care preparations (HS 3304.99) in 2025 included the United States (€742 million), the United Kingdom (€590 million) and China (€453 million). (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU imports of other beauty or make-up and skin-care preparations (HS 3304.99) from South Korea were €155.0 million in June 2026, against €76.4 million in June 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
- EU imports of other beauty or make-up and skin-care preparations (HS 3304.99) from South Korea were €127.5 million in August 2026, against €72.3 million in August 2025. (Eurostat Comext (EU trade by HS heading, DS-045409), Oct 2026)
Values are EU27 imports from non-EU countries in current euros, from Eurostat Comext. Monthly 2026 values are provisional and may be revised. Partners are listed by value, not by a Eurostat ranking. These EU import figures are not compared with Korea's own export statistics, which use a different product category and currency.
How much skincare does South Korea export?
Basic skincare is the bulk of what South Korea sells abroad as cosmetics, and the country's cosmetics exports reached a record in 2025, with new monthly records in 2026. The United States became the biggest market for Korean cosmetics in 2025, ahead of China.
- South Korea's basic skincare exports rose 11.5% in 2025 from $7,654 million in 2024, when skincare made up 75.2% of its cosmetics exports. (MFDS (2025 cosmetics statistics), May 2026)
- Colour cosmetics made up 13.2% of South Korea's cosmetics exports in 2025. (MFDS (2025 cosmetics statistics), May 2026)
- South Korea's total cosmetics exports reached a record $11.4 billion in 2025, up 11.8% from $10.2 billion in 2024. (MFDS (2025 cosmetics statistics), May 2026)
- MFDS ranks South Korea the world's second-largest cosmetics exporter in 2025, after France ($24.3 billion) and ahead of the US ($10.8 billion). (MFDS (2025 cosmetics statistics), May 2026)
- South Korea's cosmetics trade surplus passed $10 billion for the first time in 2025, at $10.1 billion with imports of $1.29 billion, and made up 12.9% of the country's total trade surplus. (MFDS (2025 cosmetics statistics), May 2026)
- The US was the largest market for Korean cosmetics in 2025 at $2.2 billion (19.1% of exports), ahead of China ($2.0 billion, down 19%) and Japan ($1.1 billion, up 4.9%). (MFDS (2025 cosmetics statistics), May 2026)
- Korean cosmetics were exported to 202 countries in 2025, up from 172 in 2024. (MFDS (2025 cosmetics statistics), May 2026)
- Korean cosmetics exports to Poland rose 115% to $280 million in 2025. (MFDS (2025 cosmetics statistics), May 2026)
- South Korea's cosmetics exports hit an all-time monthly high of $1.51 billion in September 2026, up 31.4% on a year earlier, on customs-basis trade figures. (Ministry of Trade and Industry, Korea (September 2026 trade), Oct 2026)
- Korean cosmetics exports were $1.44 billion in October 2026, up 57.5% year on year and the highest October on record, led by the US with gains in China and the EU. (Ministry of Trade and Industry, Korea (October 2026 trade), Nov 2026)
MFDS figures are Korea's national approved cosmetics statistics for calendar 2025, in current US dollars; basic skincare is MFDS's category for products such as lotions, creams, essences and masks. Totals, rankings and market figures cover all cosmetics. The monthly 2026 figures are customs-basis trade data from the Ministry of Trade and Industry, a different release and classification, and are not added to MFDS totals. MFDS's skincare category is not compared with EU trade under HS 3304.99.
How much skincare does South Korea make?
Skincare is more than half of Korean cosmetics production by value, and packs and masks grew fastest within it in 2025. Sunscreen and whitening output rose while anti-wrinkle products fell, and thousands of companies now report production to the regulator.
- South Korea produced KRW 10.32 trillion of basic skincare products in 2025, 57.5% of total cosmetics production, which reached a record KRW 17.94 trillion, up 2.3%. (MFDS (2025 cosmetics statistics), May 2026)
- Within skincare, packs and masks had the biggest rise in Korean production in 2025, up 28.3%. (MFDS (2025 cosmetics statistics), May 2026)
- Korean production of functional cosmetics (whitening, sunscreen, anti-wrinkle and multi-function products) was KRW 7.18 trillion in 2025, 40.0% of all cosmetics output. (MFDS (2025 cosmetics statistics), May 2026)
- Korean output of sunscreen products rose 9.4% in 2025 and output of whitening products 9.7%. (MFDS (2025 cosmetics statistics), May 2026)
- Production of UV-protection functional cosmetics (sunscreens) was KRW 470.3 billion in 2025, up from KRW 429.9 billion in 2024. (MFDS (2025 cosmetics statistics), May 2026)
- Anti-wrinkle functional cosmetics production fell to KRW 2.00 trillion in 2025 from KRW 2.56 trillion in 2024, while multi-function products rose to KRW 3.49 trillion, 19.4% of all cosmetics output, and whitening products to KRW 415.4 billion. (MFDS (2025 cosmetics statistics), May 2026)
- 15,342 companies reported cosmetics production to MFDS for 2025, up from 3,840 in 2015, covering 145,360 products. (MFDS (2025 cosmetics statistics), May 2026)
- South Korea had 4,158 cosmetics manufacturers and 28,412 responsible sellers at the end of 2025. (MFDS (2025 cosmetics statistics), May 2026)
- LG H&H's The History of Whoo Cheongidan Hwahyun Emulsion was South Korea's top-produced cosmetic item in 2025, at KRW 260.4 billion, down from KRW 368.8 billion in 2024. (MFDS (2025 cosmetics statistics), May 2026)
- Among contract manufacturers (ODM), Cosmax produced KRW 1.61 trillion of cosmetics in 2025 and Kolmar Korea KRW 1.30 trillion; among brand owners, LG H&H produced KRW 3.92 trillion and Amorepacific KRW 3.03 trillion. (MFDS (2025 cosmetics statistics), May 2026)
MFDS production figures are values reported by companies, in current won, on a manufacturer basis, not retail sales. Functional cosmetics are a Korean regulatory class whose claims MFDS reviews; in Korea sunscreens are functional cosmetics, not drugs. Single-function UV products are counted under UV protection, and products combining claims under multi-function. Company production totals cover all cosmetics categories.
How are sunscreens regulated in the US and Australia?
In the US, sunscreens are over-the-counter drugs, and the FDA is still reviewing most of the filters allowed on the market; in 2026 it added bemotrizinol and removed two filters no US product uses. Australia regulates sunscreens as therapeutic goods and has recalled products that did not meet their SPF claims.
- Proposed GRASE (zinc oxide, titanium dioxide) 2
- Proposed not GRASE (PABA, trolamine salicylate) 2
- Additional data needed 12
- FDA says 12 other sunscreen active ingredients, including oxybenzone, avobenzone, homosalate and octocrylene, need additional data, so its proposed order does not propose GRASE status for them. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- On 10 September 2026 FDA issued a final order removing PABA and trolamine salicylate from the active ingredients allowed in US OTC sunscreens; it says it is not aware of any US sunscreen now sold that contains them. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- FDA added bemotrizinol as a sunscreen active ingredient to the US OTC monograph on 10 June 2026 (final order OTC000039), following a request from DSM Nutritional Products. (FDA (OTC sunscreen regulatory actions Q&A), Jun 2026)
- FDA received over 15,000 public comments on its 2021 sunscreen proposed order. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- FDA has proposed a maximum labelled SPF of "SPF 60+" for US sunscreens, while allowing products formulated up to SPF 80; this is a proposal, not a final rule. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- FDA has also proposed that all sunscreens of SPF 15 and above be broad spectrum, with a UVA I/UV ratio of 0.7 or higher. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- FDA proposes that zinc oxide and titanium dioxide are GRASE in sunscreens at concentrations of up to 25%. (FDA (OTC sunscreen regulatory actions Q&A), Sep 2026)
- Australia's TGA cancelled 19 sunscreens from the Australian Register of Therapeutic Goods and recalled them after reviewing products that shared the base formulation of Ultra Violette Lean Screen SPF 50+, which had shown lower than claimed SPF results. (TGA (listed medicine compliance, March 2026), Mar 2026)
- In a June 2025 test reported by the TGA, the consumer group CHOICE found that 16 of the 20 sunscreens it tested did not meet their claimed SPF 50+ rating, and one tested at SPF 4. (TGA (sunscreen SPF testing information), Sep 2025)
- Applied correctly, an SPF 30 sunscreen filters about 97% of UVB rays and an SPF 50 about 98%, and even SPF 20 filters about 95%, according to the TGA. (TGA (sunscreen SPF testing information), Sep 2025)
FDA figures describe the US OTC sunscreen monograph as FDA states it in September 2026. The 2021 proposed order is not final, and FDA says that withholding GRASE status because more data is needed is not a finding that an ingredient is unsafe. PABA and trolamine salicylate have since been removed by final order. The CHOICE results are a consumer group's test, restated by the TGA. US and Australian rules are not compared.
Which sunscreen filters and skincare ingredients does the EU limit?
The EU has cut the amounts of several UV filters and popular skincare actives allowed in cosmetics since 2022, after opinions from its Scientific Committee on Consumer Safety (SCCS). The limits cover oxybenzone, octocrylene and homosalate in sun products and vitamin A, arbutin and kojic acid in skincare.
- The EU caps benzophenone-3 (oxybenzone) at 6% in face cream, hand cream and lip products and 2.2% in body creams and sunscreen sprays, after the SCCS found the previous 6% limit not safe in body sunscreens. (European Commission (Regulation (EU) 2022/1176), Jul 2022)
- The EU limits octocrylene in cosmetics to 10%, and to 9% in sunscreen propellant sprays. (European Commission (Regulation (EU) 2022/1176), Jul 2022)
- The EU restricted the UV filter homosalate to face products only, at a maximum of 7.34%, down from 10% in any product, after the SCCS concluded it was not safe at up to 10%. (European Commission (Regulation (EU) 2022/2195), Nov 2022)
- The EU limits retinol, retinyl acetate and retinyl palmitate (vitamin A) to 0.05% retinol equivalent in body lotion and 0.3% in other leave-on and rinse-off products, following a 2022 SCCS opinion. (European Commission (Regulation (EU) 2024/996), Apr 2024)
- Alpha-arbutin is capped at 2% in face creams and 0.5% in body lotions, and arbutin at 7% in face creams, with hydroquinone in such products kept to unavoidable trace levels. (European Commission (Regulation (EU) 2024/996), Apr 2024)
- The EU restricts kojic acid to skin-lightening use in face and hand products, at a maximum of 1%. (European Commission (Regulation (EU) 2024/996), Apr 2024)
Limits are maximum concentrations in ready-for-use products under the EU Cosmetics Regulation (EC) No 1223/2009, as amended by Commission Regulations (EU) 2022/1176, 2022/2195 and 2024/996. Each regulation sets its own transition period for products already on the market; those dates are not given here. In the US, sunscreen filters are regulated as drugs, so these EU limits are not compared with FDA rules.
How often are cosmetics and skin products found unsafe?
Cosmetics were the product group most often reported in the EU's Safety Gate alert system in 2025, mostly for a banned fragrance. In the US, FDA tests keep finding mercury in skin-lightening creams sold online.
- Cosmetics were the most frequently reported dangerous product category in the EU's Safety Gate system in 2025, at 36% of 4,671 alerts, ahead of toys (16%) and electrical appliances and equipment (11%). (European Commission (Safety Gate report 2025), Mar 2026)
- Almost eight in 10 Safety Gate alerts on cosmetics in 2025 related to BMHCA (butylphenyl methylpropional, or lilial), a banned synthetic fragrance; the Commission spells it "BMCHA". (European Commission (Safety Gate report 2025), Mar 2026)
- Dangerous chemicals were the leading risk in 2025 Safety Gate alerts across all products, at 53% of notifications, and national authorities took a record 5,794 follow-up actions, up 35%. (European Commission (Safety Gate report 2025), Mar 2026)
- Under the Modernization of Cosmetics Regulation Act (MoCRA), FDA had 16,398 unique, active cosmetic product facility registrations and 1,298,361 unique, active cosmetic product listings as of 30 June 2026; registration is not FDA approval. (FDA (cosmetics registration and listing), Sep 2026)
- FDA laboratory tests in 2026 found mercury at 27,762 parts per million in Orbi 20 Whitening Cream and 19,027 ppm in Deluxe Silken Bleaching Cream, both bought on eBay. (FDA (skin products containing mercury), Aug 2026)
- Dr. Yanhee Cream Set (Blue), bought on eBay and tested in 2026, contained 10,668 ppm of mercury; FDA says there are "no FDA-approved or legally marketed OTC skin lightening products". (FDA (skin products containing mercury), Aug 2026)
- FDA sent warning letters to 12 companies in April 2022 for selling OTC skin-lightening products containing hydroquinone; under the CARES Act, such products without FDA approval have had to come off the US market since 23 September 2020. (FDA (OTC skin lightening products), Apr 2022)
Safety Gate covers non-food consumer products in the EU and EEA; its cosmetics category is not split into skin care and other products. MoCRA figures cover all cosmetics; US sunscreens are drugs and are not in these listings. Mercury results are FDA tests of individual products, not market surveys.
How common are sunburn and melanoma in the US?
Sunburn is common among US adults, and many burn even when they have used sunscreen. Most US melanomas are found at the localized stage, when five-year survival is very high, but the outlook is far worse once the cancer has spread.
View data table
| Period | Value |
|---|---|
| All stages | 94.7% |
| Localized | 100.0% |
| Distant | 34.0% |
- An estimated 18.8 million US adults (7.5%) had four or more sunburns in the previous 12 months in 2024. (CDC (MMWR, sunburn among US adults 2024), May 2026)
- 55.1% of US adults who had a sunburn in 2024 said their most recent sunburn happened even though they had used sunscreen. (CDC (MMWR, sunburn among US adults 2024), May 2026)
- In 2020, 12.3% of US men and 29.0% of US women aged 18 and over always used sunscreen when outside on a sunny day for more than an hour. (CDC NCHS (MMWR QuickStats, sunscreen use 2020), Jun 2022)
- An estimated 8,510 people will die of melanoma of the skin in the US in 2026. (NCI SEER (Cancer Stat Facts: Melanoma of the Skin), Nov 2026)
- The US rate of new melanoma cases was 22.3 per 100,000 people a year (2019-2023 cases) and the death rate 2.0 per 100,000 (2020-2024 deaths), both age-adjusted to the 2000 US standard population. (NCI SEER (Cancer Stat Facts: Melanoma of the Skin), Nov 2026)
- About 2.2% of people in the US will be diagnosed with melanoma of the skin at some point in their lifetime, on 2021-2023 data. (NCI SEER (Cancer Stat Facts: Melanoma of the Skin), Nov 2026)
- Five-year relative survival for melanoma of the skin in the US is 94.7% (2016-2022); it is 100.0% when the cancer is found at the localized stage, as 77% of cases are, and 34.0% when it has spread to distant sites. (NCI SEER (Cancer Stat Facts: Melanoma of the Skin), Nov 2026)
- An estimated 1,573,288 people were living with melanoma of the skin in the US in 2023, and the median age at diagnosis is 67. (NCI SEER (Cancer Stat Facts: Melanoma of the Skin), Nov 2026)
CDC figures are self-reported answers to the National Health Interview Survey (2024 for sunburn, 2020 for sunscreen use); the 2020 figure counts only those who "always" use sunscreen. SEER figures for 2026 are projections, and rates come from SEER cancer registries. Relative survival excludes other causes of death. Nothing here shows that any skincare product prevents melanoma. US rates are not compared with Australian or global rates, which use different age standards.
How common is melanoma worldwide, in Australia and in the UK?
Melanoma is a major cancer in Australia, where diagnoses have risen for four decades, and in the UK, where Cancer Research UK judges most cases preventable. Each producer counts and age-standardises differently, so countries are not ranked against each other.
- There were an estimated 337,969 new cases of melanoma of the skin worldwide in 2024 and 58,398 deaths, on IARC's GLOBOCAN 2024 estimates. (IARC (GLOBOCAN 2024, melanoma of skin fact sheet), Jul 2026)
- Melanoma ranked 17th among cancers by new cases worldwide in 2024, with an age-standardised incidence of 3.1 per 100,000 on the world standard population. (IARC (GLOBOCAN 2024, melanoma of skin fact sheet), Jul 2026)
- Europe had an estimated 150,781 new melanoma cases in 2024 (44.6% of the world total), Northern America 111,521 (33.0%) and Oceania 22,145 (6.6%). (IARC (GLOBOCAN 2024, melanoma of skin fact sheet), Jul 2026)
- An estimated 596,731 people in Europe were living within five years of a melanoma diagnosis in 2024 (45.6% of the world total), and 448,427 in Northern America. (IARC (GLOBOCAN 2024, melanoma of skin fact sheet), Jul 2026)
- An estimated 17,443 new cases of melanoma of the skin will be diagnosed in Australia in 2025, 10% of all new cancer cases, making it the third most commonly diagnosed cancer there. (Cancer Australia (melanoma of the skin statistics), Dec 2025)
- Australia's age-standardised melanoma incidence rate is estimated at 63 cases per 100,000 people in 2025 (78 for males and 50 for females), on Cancer Australia's Australian standard population. (Cancer Australia (melanoma of the skin statistics), Dec 2025)
- Australian melanoma diagnoses rose from 3,561 in 1982 to 15,034 in 2021, and the age-standardised rate rose from 30 to 60 cases per 100,000. (Cancer Australia (melanoma of the skin statistics), Dec 2025)
- Australians have an estimated 1 in 19 (5.4%) risk of being diagnosed with melanoma of the skin by age 85: 1 in 16 for males and 1 in 23 for females. (Cancer Australia (melanoma of the skin statistics), Dec 2025)
- An estimated 1,455 Australians will die from melanoma of the skin in 2025, 2.7% of cancer deaths; 1,527 died of it in 2023. (Cancer Australia (melanoma of the skin statistics), Dec 2025)
- The UK records about 19,392 new cases of melanoma skin cancer a year (2019 and 2021-2022) and about 2,600 deaths a year (2022-2024). (Cancer Research UK (melanoma skin cancer statistics), Nov 2026)
- Cancer Research UK estimates that 86% of melanoma skin cancer cases in the UK are preventable, on a 2015 estimate. (Cancer Research UK (melanoma skin cancer statistics), Nov 2026)
- 92.7% of people with melanoma skin cancer in the UK survive for 10 or more years, on Cancer Research UK's 2018 figure. (Cancer Research UK (melanoma skin cancer statistics), Nov 2026)
- In England, 66% of melanoma skin cancer cases diagnosed in 2019 were found through an urgent suspected cancer (two week wait) referral, and 3% through an emergency presentation. (Cancer Research UK (melanoma skin cancer statistics), Nov 2026)
GLOBOCAN 2024 figures are IARC modelled estimates using the world standard population; the 2024 edition replaces the 2022 one, and editions are not mixed. Cancer Australia uses an Australian standard population, and its 2025 figures are projections. SEER uses the 2000 US standard. Cancer Research UK compiles data from the UK's four cancer registries and gives counts here, not rates. Rates on different standards are not comparable, so countries are not ranked across producers.
Glossary
- Like-for-like (LFL)
- L'Oréal's growth measure at constant group structure and exchange rates. Shiseido and Kao use their own like-for-like definitions.
- Organic growth
- Sales growth excluding currency effects, on each company's own definition (Estée Lauder, Beiersdorf). Galderma reports growth at constant currency.
- Dermocosmetics
- Skincare sold with a dermatological positioning, such as La Roche-Posay, CeraVe, Eucerin and Cetaphil. Each company defines its own division or category.
- Net manufacturer prices
- The prices manufacturers receive, before retail margins and taxes. L'Oréal's market estimate uses this basis; Cosmetics Europe uses retail sales values.
- HS 3304.99
- The Harmonized System trade code for other beauty or make-up preparations and preparations for the care of the skin, including sunscreen and tanning preparations, excluding medicaments. It is wider than skincare alone.
- Comext and Prodcom
- Eurostat's databases of EU international trade and of the sold production of manufactured goods. Prodcom 20421500 covers beauty, make-up and skin care preparations including suntan products.
- MFDS
- South Korea's Ministry of Food and Drug Safety, which regulates cosmetics and publishes national cosmetics production and trade statistics. Its "basic skincare" category covers products such as lotions, creams, essences and masks.
- Functional cosmetics
- A Korean regulatory class of cosmetics with reviewed claims, such as whitening, wrinkle improvement and UV protection.
- ODM
- Original design manufacturer: a contract maker that develops and produces cosmetics for other brands, such as Cosmax and Kolmar Korea.
- GRASE and OTC monograph
- Generally recognized as safe and effective, the FDA standard for an over-the-counter drug ingredient, and the FDA rulebook that sets which ingredients OTC sunscreens may use.
- SPF and broad spectrum
- Sun protection factor, a measure of protection against UVB rays. Broad spectrum products also protect against UVA rays.
- SCCS
- The EU Scientific Committee on Consumer Safety, whose opinions underpin EU limits on cosmetic ingredients.
- Safety Gate
- The EU rapid alert system for dangerous non-food products, run by the European Commission with national authorities.
- MoCRA
- The US Modernization of Cosmetics Regulation Act of 2022, under which cosmetic facilities register with FDA and products are listed.
- CPI-U
- The US consumer price index for all urban consumers, published by the Bureau of Labor Statistics. Index values track price change against 1982-84=100.
- SEER, GLOBOCAN and age-standardised rate
- SEER is the US National Cancer Institute's cancer registry programme; GLOBOCAN is the International Agency for Research on Cancer's set of world cancer estimates. An age-standardised rate adjusts for age using a standard population, which differs between producers.
- Fiscal year
- A company's own financial year: to 30 June for Estée Lauder and P&G, to around 31 January for Ulta Beauty, and the calendar year for L'Oréal, Beiersdorf, Galderma, Shiseido, Kao and Amorepacific.
Methodology and sources
Figures come from official statistics and regulators (Eurostat, the US Bureau of Labor Statistics, FDA, CDC and the National Cancer Institute, Korea's Ministry of Food and Drug Safety and Ministry of Trade and Industry, Australia's Therapeutic Goods Administration and Cancer Australia, and the European Commission), the International Agency for Research on Cancer, Cancer Research UK, the industry body Cosmetics Europe, and companies' own annual reports, filings and results releases (L'Oréal, Beiersdorf, Galderma, the Estée Lauder Companies, P&G, Ulta Beauty, Shiseido, Kao and Amorepacific). Market estimates carry their producer and basis: L'Oréal's world estimate at manufacturer prices and Cosmetics Europe's European retail figures are never combined. EU trade under HS 3304.99 is described by its tariff heading, which covers make-up and sunscreen as well as skin care, and is not compared with Korea's skincare category. Company figures carry their financial year and say whether they cover a category, a division or the whole group. Melanoma rates are given with their producer and age standard, and countries are not ranked across producers. Forecasts are labelled as forecasts. Only figures checked on the publisher's own page or file are used. The page is reviewed monthly and the date is shown at the top.
- Amorepacific Group (2025 results) · Feb 2026
- Beiersdorf (2025 results) · Mar 2026
- Beiersdorf (H1 2026 results) · Aug 2026
- Beiersdorf (Q3 2026 results) · Oct 2026
- BLS (CPI-U series CUUR0000SEGB, 12-month change) · Nov 2026
- BLS (CPI-U series CUUR0000SEGB02, 12-month change) · Nov 2026
- BLS (CPI-U series CUUR0000SEGB02) · Nov 2026
- Cancer Australia (melanoma of the skin statistics) · Dec 2025
- Cancer Research UK (melanoma skin cancer statistics) · Nov 2026
- CDC (MMWR, sunburn among US adults 2024) · May 2026
- CDC NCHS (MMWR QuickStats, sunscreen use 2020) · Jun 2022
- Cosmetics Europe (Our Industry) · Nov 2026
- Cosmetics Europe (socio-economic infographic 2026) · Oct 2026
- Estée Lauder Companies (FY2026 results) · Aug 2026
- Estée Lauder Companies (Q1 FY2027 results) · Nov 2026
- European Commission (Regulation (EU) 2022/1176) · Jul 2022
- European Commission (Regulation (EU) 2022/2195) · Nov 2022
- European Commission (Regulation (EU) 2024/996) · Apr 2024
- European Commission (Safety Gate report 2025) · Mar 2026
- Eurostat (Prodcom sold production, DS-059358) · Oct 2026
- Eurostat Comext (EU trade by HS heading, DS-045409) · Oct 2026
- FDA (cosmetics registration and listing) · Sep 2026
- FDA (OTC skin lightening products) · Apr 2022
- FDA (OTC sunscreen regulatory actions Q&A) · Sep 2026
- FDA (skin products containing mercury) · Aug 2026
- Galderma (2025 results) · Mar 2026
- Galderma (Q3 2026 results) · Oct 2026
- IARC (GLOBOCAN 2024, melanoma of skin fact sheet) · Jul 2026
- INTAGE via Kao (FY2025 results) · Feb 2026
- L'Oréal (2025 Universal Registration Document) · Mar 2026
- L'Oréal (sales at 30 September 2026) · Oct 2026
- MFDS (2025 cosmetics statistics) · May 2026
- Ministry of Trade and Industry, Korea (October 2026 trade) · Nov 2026
- Ministry of Trade and Industry, Korea (September 2026 trade) · Oct 2026
- NCI SEER (Cancer Stat Facts: Melanoma of the Skin) · Nov 2026
- P&G (Form 10-K fiscal 2026) · Aug 2026
- Shiseido (FY2025 earnings call) · Feb 2026
- Shiseido (FY2025 results presentation) · Feb 2026
- TGA (listed medicine compliance, March 2026) · Mar 2026
- TGA (sunscreen SPF testing information) · Sep 2025
- Ulta Beauty (Form 10-K fiscal 2025) · Mar 2026